SECURITIES AND EXCHANGE COMMISSION 

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

Pursuant to Rule 13a-16 or 15d-16 of the 

Securities Exchange Act of 1934

For the month of July 2023

Commission file number: 001-32749

FRESENIUS MEDICAL CARE AG & Co. KGaA 

(Translation of registrant's name into English)

Else-Kröner Strasse 1 

61346 Bad Homburg 

Germany 

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F X     x             Form 40-F  ¨

This Form 6-K, including all exhibits hereto, is hereby incorporated by reference into the registration statement on Form F-4 filed by the registrant under the Securities Act of 1933, Registration No. 333-271081, which was declared effective by the SEC on June 6, 2023.

EXHIBITS

The following exhibits are being furnished with this Report:

Exhibit 99.1 Press Release issued on July 10, 2023.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

DATE: July 10, 2023

Fresenius Medical Care AG & Co. KGaA, 

a partnership limited by shares, represented by:

fresenius medical care management ag, its 

General Partner

By:	/s/ Helen Giza
Name:	Helen Giza
Title:	Chief Executive Officer, Chair of the Management Board of the General Partner and Acting Chief Financial Officer
By:	/s/ Dr. Katarzyna Mazur-Hofsäß
Name:	Dr. Katarzyna Mazur-Hofsäß
Title:	CEO Care Enablement and member of the Management Board of the General Partner